Delivery Order SPE2DP21D0006-SPE2DP21F2380
Award Date
2/26/21
Potential Completion Date
8/20/21
Potential Value
$17M
Federal Agency
Medical Supply Chain
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
339112 - Surgical and Medical Instrument Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical awarded Glaxosmithkline, LLC a $127,000 firm fixed price delivery order contract to provide influenza virus vaccinations. As the prime contractor, Glaxosmithkline will deliver the requested vaccinations from their Research Triangle Park, North Carolina facility to support DLA Troop Support Medical's influenza virus vaccination program. No major subcontractors or set aside designations were identified. This delivery order was issued against an...
The Defense Logistics Agency Troop Support Medical awarded Glaxosmithkline, LLC a $2.4 million firm fixed price delivery order contract to provide influenza virus vaccinations. As the prime contractor, Glaxosmithkline will deliver the vaccinations from its Research Triangle Park, North Carolina facility to support DLA Troop Support Medical's influenza virus vaccination program. The delivery order was issued against an unspecified governmentwide acquisition contract vehicle and has a...
The Defense Logistics Agency Troop Support Medical awarded Glaxosmithkline, LLC a $463,000 firm fixed price delivery order contract to supply influenza virus vaccines. As the prime contractor, Glaxosmithkline will deliver the vaccines from its Research Triangle Park, North Carolina facility to support DLA Troop Support Medical's influenza virus vaccination program. The contract runs from March 22, 2021 through November 12, 2021. No set aside designation or subcontractors were indicated. DLA...
<p>The Defense Logistics Agency Troop Support Medical awarded an $18.8 million firm fixed price delivery order contract to Glaxosmithkline, LLC for Influenza Virus Vaccines. The prime contractor Glaxosmithkline, LLC will perform the work at their facility located in Research Triangle Park, North Carolina. The period of performance is from August 31, 2022 through August 31, 2022. No applicable subcontractors were identified.</p>
<p>The Defense Logistics Agency Troop Support Medical awarded an $2.635 million firm fixed price delivery order contract to Glaxosmithkline, LLC for Influenza Virus Vaccines. The prime contractor Glaxosmithkline, LLC will provide the vaccines from their location in Research Triangle Park, North Carolina. The contract period of performance is from August 31, 2022 through August 31, 2022.</p>
The Defense Logistics Agency Troop Support Medical awarded a $217,170 delivery order to Glaxosmithkline, LLC for influenza virus vaccinations. Glaxosmithkline will deliver the requested vaccinations as the prime contractor, performing the work out of its Research Triangle Park, North Carolina facility. The firm fixed price contract runs from March 22, 2021 through November 12, 2021 to support the Defense Logistics Agency's medical programs. No set aside designation or subcontractors were...
<p>The Defense Logistics Agency Troop Support Medical awarded Glaxosmithkline, LLC a $12.3 million firm fixed price delivery order contract to provide Influenza Virus Vaccines. Glaxosmithkline will perform the work as the prime contractor from their location in Research Triangle Park, North Carolina, between March 4, 2022 and August 31, 2022.</p>
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of 8502637428 influenza virus vaccine. The $100,660.00 contract has a performance period ending on November 30, 2015 and was not set aside for any socioeconomic category. Glaxosmithkline holds multiple federal contract vehicles with agencies like the Department of Veterans Affairs, Centers for Disease Control and Prevention, and DLA to...
This is a federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, from the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $3,820.80 and is a firm fixed price delivery order with a completion date of November 12, 2018. The contract does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and...
This federal contract award, SPE2DP18D0006|SPE2DP19F0375, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The $53,730.00 firm fixed price delivery order has a period of performance ending on November 7, 2018 and was placed under a larger DLA pharmaceutical supply contract vehicle. The contract does not have a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has also received other...